Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma
Open Access
- 15 September 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (18), 3830-3840
- https://doi.org/10.1158/0008-5472.CAN-20-0754
Abstract
Chromophobe renal cell carcinoma (chRCC) and renal oncocytoma are closely related, rare kidney tumors. Mutations in complex I (CI)-encoding genes play an important role in dysfunction of the oxidative phosphorylation (OXPHOS) system in renal oncocytoma, but are less frequently observed in chRCC. As such, the relevance of OXPHOS status and role of CI mutations in chRCC remain unknown. To address this issue, we performed proteome and metabolome profiling as well as mitochondrial whole-exome sequencing to detect mitochondrial alterations in chRCC tissue specimens. Multiomic analysis revealed downregulation of electron transport chain (ETC) components in chRCC that differed from the expression profile in renal oncocytoma. A decrease in mitochondrial (mt)DNA content, rather than CI mutations, was the main cause for reduced OXPHOS in chRCC. There was a negative correlation between protein and transcript levels of nuclear DNA- but not mtDNA-encoded ETC complex subunits in chRCC. In addition, the reactive oxygen species scavenger glutathione (GSH) was upregulated in chRCC due to decreased expression of proteins involved in GSH degradation. These results demonstrate that distinct mechanisms of OXPHOS exist in chRCC and renal oncocytoma and that expression levels of ETC complex subunits can serve as a diagnostic marker for this rare malignancy. Significance: These findings establish potential diagnostic markers to distinguish malignant chRCC from its highly similar but benign counterpart, renal oncocytoma.Other Versions
Funding Information
- chRCC (UOK276)
This publication has 55 references indexed in Scilit:
- Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomasVirchows Archiv, 2013
- The Proteomics Identifications (PRIDE) database and associated tools: status in 2013Nucleic Acids Research, 2012
- Spectrum of somatic mitochondrial mutations in five cancersProceedings of the National Academy of Sciences, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- 2009 update on the classification of renal epithelial tumors in adultsInternational Journal of Urology, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Loss of Complex I due to Mitochondrial DNA Mutations in Renal OncocytomaClinical Cancer Research, 2008
- Glutathione and apoptosisFree Radical Research, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinomaCarcinogenesis: Integrative Cancer Research, 2004